MIKE ONEILL

Editor & Publisher, BioQuick News

[MIKE ONEILL @bioquicknews]

Bio-IT World Conference & Expo—Day 3
https://t.co/HduzpWgfDy
#BioIT2024

[MIKE ONEILL @bioquicknews]

Bio-IT World Conference & Expo—Day 1
https://t.co/zOrf5XCZ4o
#BioIT2024

[MIKE ONEILL @bioquicknews]

Bio-IT World Conference & Expo—Day 2
https://t.co/I7bA8xNlld
#BioIT2024

[MIKE ONEILL @bioquicknews]

21 Stories on #AACR24 posted in BioQuick News.
#AACR24
https://t.co/y1DgEz4JyY

[MIKE ONEILL @bioquicknews]

Sensational 6-Day AACR 2024 Annual Meeting Closes with Plenary, Research Sessions, a Poem to AI, and Meeting Wrap-Up
#AACR24
https://t.co/iyPY4oHOmp

[MIKE ONEILL @bioquicknews]

An Exosome-Based Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer
https://t.co/yKUSdbt7wi
#AACR24

[MIKE ONEILL @bioquicknews]

Long Day of Spectacular Science for 22,000 Attendees at AACR 2024 Annual Meeting—Sunday Highlights
https://t.co/iKzXYkTaPX
#AACR24

[MIKE ONEILL @bioquicknews]

Moderna & Merck Announce mRNA-4157/V940, an Investigational
Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA® (Pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial in Stage III/IVMelanoma; Resul…https://t.co/ZzI3UxXxey https://t.co/ybYnlUqlW5

[MIKE ONEILL @bioquicknews]

Moderna & Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA® (Pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial in Stage III/IVMelanoma; Resul…https://t.co/3pt5a4gjyI https://t.co/ybYnlUqlW5

[MIKE ONEILL @bioquicknews]

#PrecisionMedicineWorldConference (#PMWC) 2023 to Be Held January 25-27 in Silicon Valley
@PMWC
@PMWC2023
@Precision Medicine

[MIKE ONEILL @bioquicknews]

#CRISPR Technology Directly Targeting #RNA Improves #Huntington’sDisease Symptoms in Models
@Huntington's Disease
@CRISPR
@RNA https://t.co/rhFfpIySVU

[MIKE ONEILL @bioquicknews]

#Aging Associated with Systemic Length-Associated #Transcriptome Imbalance; Aging Is Accompanied by Shift in Gene Activity Toward Shorter Gene Transcripts, Which Are Associated with #AcceleratedAging; Longer Gene Transcripts Associated with Longer #Lifesp…https://t.co/Cl9p23tx8T

[MIKE ONEILL @bioquicknews]

High-Quality, #Haplotype-Phased #Genome Reconstruction Reveals Unexpected #HaplotypeDiversity in Economically Important Japanese #PearlOyster #Pinctadafucata; Knowledge May Guide Enhancements of Disease Resistance in Faltering #Pearl Industry https://t.co/n3wCrdEgI4

[MIKE ONEILL @bioquicknews]

Study Sets Basis for Identifying #Exosome-Carried #Biomarkers of #Latent #MalariaVivax Infections; Using Mouse Model, Research Team Characterized #ProteinProfile of #Exosomes Released By #Liver Cells, Where #LatentFormofParasite Hides https://t.co/d5KGV1LLxq

[MIKE ONEILL @bioquicknews]

Early Diagnosis Tool for #Childhood #KidneyDisease: Analysis of Urinary #ExtracellularVesicles (#EVs); New Technique Can Detect Damage to Children’s #Kidneys Earlier Than Current Tests https://t.co/Tc785DM3cd

[MIKE ONEILL @bioquicknews]

Researchers Reveal #Exosome-Related Reason Why #Shingles Can Cause #Strokes https://t.co/GYn5FBbqom

[MIKE ONEILL @bioquicknews]

#MountSinai Launches #LargeScaleGeneticSequencing Project (“#MillionHealthDiscoveries”) with #RegeneronGeneticsCenter; Project Aims to Enroll One Million Racially and Ethnically Diverse Patients, Advance #PrecisionMedicine Research…https://t.co/A1qySUMlxl https://t.co/DgxXAXPoNB

[MIKE ONEILL @bioquicknews]

#OldestHumanDNA in UK Obtained, Revealing Two Distinct Paleolithic Populations
#UCL
#NaturalHistoryMuseum
#FrancisCrickInstitute https://t.co/TFFX7I17FT

[MIKE ONEILL @bioquicknews]

Researchers Show #SpleenTyrosineKinase (#SYK) Protein May Hold Key to Boosting Brain’s Ability to Fight #Alzheimer’s, #MS, Other #NeurologicalDiseases; Article Published in #Cell https://t.co/EnhaXJ50D3

[MIKE ONEILL @bioquicknews]

Researchers from #HokkaidoUniversity and #Toppan Have Developed an #Exosome-Based Method to Detect Build-Up of #AmyloidBeta (AB) in the #Brain, a Characteristic of #Alzheimer’sDisease; Test Detects #Exosome-Bound AB Surface #Biomarkers in #BloodSamples https://t.co/svupes7nuT